Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

iECURE
620 West Germantown Pike, Suite 220
Plymouth Meeting, PA 19462
Phone: 267-817-4800
https://iecure.com/

iECURE is a gene editing company focused on developing therapies that utilize mutation-agnostic in vivo gene insertion, or knock-in, editing for the treatment of liver disorders with significant unmet need. We believe our approach has the potential to replace and restore the function of a dysfunctional gene by knocking-in a healthy copy, regardless of mutation, to offer durable gene expression and long-term, potentially curative, therapeutic benefit.

Key Contact
Name
Joseph Truitt
Title
CEO
E-Mail
Funding Events

Date
Amount
Type
Investors
Valuation
11/30/22 $65,000,000 Series A-1 LYFE Capital
Novo Holdings
OrbiMed Advisors
Versant Ventures
undisclosed